Search

Home
Staff
Sarah Al Ashmori Theophile Bigirumurame Andy Bryant Bram Burger Thomas Chadwick Svetlana Cherlin Mike Cole Holly Fisher Tony Fouweather Michael Grayling Shaun Hiu Dorcas Kareithi Ann Breeze Konkoth Nan Lin Jingky Lozano-Kuehne John Matthews Helen Mossop Ellen Moss Jérémie Nsengimana Luke Ouma Vicky Ryan Marzieh Shahmandi Moha Shojaei Dawn Teare James Wason Faye Williamson Nina Wilson Sylvia Zhang
PhD students
Ruqayya Azher Laura Etfer Aritra Mukherjee Pela Okorie Samuel Sarkodie Lou Whitehead
Methodology research
Overview Adaptive designs Master protocols Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures Leveraging External Information Precision Medicine Clinical Trials
Contact

Cherlin S

Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential
Developing a predictive signature for two trial endpoints using the cross-validated risk scores method
A genome-wide association study identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 as risk loci contributing to cutaneous leishmaniasis in Brazil
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: A structured summary of a study protocol for a randomised controlled trial
Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response
Developing and testing high-efficacy patient subgroups within a clinical trial using risk scores
Generalizing rate heterogeneity across sites in statistical phylogenetics
Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data
Detecting responses to treatment with fenofibrate in pedigrees
Using penalized regression to predict phenotype from SNP data
The effect of nonreversibility on inferring rooted phylogenies
New substitution models for rooting phylogenetic trees

Published with Wowchemy — the free, open source website builder that empowers creators.